ACADIA PHARMACEUTICALS INC Quarterly Unrecognized Tax Benefits in USD from Q4 2012 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Acadia Pharmaceuticals Inc quarterly Unrecognized Tax Benefits history and growth rate from Q4 2012 to Q4 2023.
  • Acadia Pharmaceuticals Inc Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $37.1M, a 94.7% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $37.1M +$18M +94.7% Dec 31, 2023 10-K 2024-02-28
Q4 2022 $19.1M +$5.14M +36.9% Dec 31, 2022 10-K 2024-02-28
Q4 2021 $13.9M +$4.08M +41.5% Dec 31, 2021 10-K 2024-02-28
Q4 2020 $9.84M +$2.9M +41.7% Dec 31, 2020 10-K 2024-02-28
Q4 2019 $6.95M +$1.91M +37.9% Dec 31, 2019 10-K 2023-02-28
Q4 2018 $5.04M +$3.1M +161% Dec 31, 2018 10-K 2022-03-01
Q4 2017 $1.93M -$731K -27.4% Dec 31, 2017 10-K 2021-02-25
Q4 2016 $2.66M +$363K +15.8% Dec 31, 2016 10-K 2020-02-27
Q4 2015 $2.3M +$2.3M Dec 31, 2015 10-K 2019-02-27
Q4 2014 $0 $0 Dec 31, 2014 10-K 2016-02-29
Q4 2013 $0 $0 Dec 31, 2013 10-K 2016-02-29
Q4 2012 $0 Dec 31, 2012 10-K 2014-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.